- Home
- SLVM vs CPRX Comparison
SLVM vs CPRX Comparison
Compare SLVM & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLVM
- CPRX
- Stock Information
- Founded
- SLVM 1898
- CPRX 2002
- Country
- SLVM United States
- CPRX United States
- Employees
- SLVM N/A
- CPRX N/A
- Industry
- SLVM Paper
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SLVM Basic Materials
- CPRX Health Care
- Exchange
- SLVM Nasdaq
- CPRX Nasdaq
- Market Cap
- SLVM 2.4B
- CPRX 2.9B
- IPO Year
- SLVM N/A
- CPRX 2006
- Fundamental
- Price
- SLVM $53.01
- CPRX $21.46
- Analyst Decision
- SLVM Hold
- CPRX Strong Buy
- Analyst Count
- SLVM 3
- CPRX 6
- Target Price
- SLVM $85.67
- CPRX $32.83
- AVG Volume (30 Days)
- SLVM 280.2K
- CPRX 1.4M
- Earning Date
- SLVM 08-08-2025
- CPRX 08-06-2025
- Dividend Yield
- SLVM 3.41%
- CPRX N/A
- EPS Growth
- SLVM 45.44
- CPRX 178.13
- EPS
- SLVM 6.82
- CPRX 1.57
- Revenue
- SLVM $3,689,000,000.00
- CPRX $534,645,999.00
- Revenue This Year
- SLVM N/A
- CPRX $16.37
- Revenue Next Year
- SLVM $0.14
- CPRX $8.80
- P/E Ratio
- SLVM $7.77
- CPRX $13.68
- Revenue Growth
- SLVM 0.11
- CPRX 29.97
- 52 Week Low
- SLVM $49.93
- CPRX $14.97
- 52 Week High
- SLVM $98.02
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- SLVM 51.80
- CPRX 31.74
- Support Level
- SLVM $50.01
- CPRX $20.95
- Resistance Level
- SLVM $53.49
- CPRX $22.07
- Average True Range (ATR)
- SLVM 1.26
- CPRX 0.62
- MACD
- SLVM 0.47
- CPRX -0.20
- Stochastic Oscillator
- SLVM 86.52
- CPRX 13.04
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).